Another project enabled the first FDA -
approved imaging agent that could be used in PET scans of Alzheimer's patients who were still alive.
Not exact matches
The MPI that uses clinically -
approved, iron oxide - based MRI contrast
agents is capable of 3D, high - resolution
imaging in real time.
An investigational
imaging agent, if
approved, could one day contribute to patient management by helping clinicians direct biopsies and cancer therapies.
A cancer
imaging agent that was originally developed at Emory was
approved on Friday, May 27 by the U.S. Food and Drug Administration.